Skip to content

Michael F. Mullarkey, MD

NPI 1457478042ActiveIndividual· Internal Medicine, Allergy & Immunology· Seattle, WA

Internal Medicine, Allergy & Immunology (MD) in Seattle, Washington, licensed in WA, with an NPI issued in March 2007. Part D covered 28 prescriptions written in 2024, 86% of them generic. Blueprint Medicines Corporation was the largest of 2 companies reporting payments in 2025, $141.86 in all, mostly food and beverage.

Overview

NPI1457478042
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 26, 2007
Last updated in NPPESDec 20, 2012

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Allergy & Immunology Primary207RA0201XMD00015335WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)28 · 31 30-day fills
Total drug cost$269.74
Generic share86% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$141.86 · 2 payments from 2 companies
  • 2024$135.06 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Blueprint Medicines Corporation$121.301
Enterra Medical, Inc.$20.561

What the 2025 payments were for

  • Food and Beverage$141.86 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Allergy & Immunology providers in Seattle

All Internal Medicine, Allergy & Immunology providers in Washington